Highly Potent, Orally Available Anti-inflammatory Broad-Spectrum Chemokine Inhibitors
作者:David J. Fox、Jill Reckless、Hannah Lingard、Stuart Warren、David J. Grainger
DOI:10.1021/jm900133w
日期:2009.6.11
A series of 3-acylaminocaprolactams are inhibitors of chemokine-induced chemotaxis. Branching of the side chain alpha-carbon provides highly potent inhibitors of a range of CC and CXC chemokines. The most potent compound has an ED50 of 40 pM. Selected compounds were tested in an in vivo inflammatory assay, and the best compound reduces TNF-alpha levels with an ED50 of 0.1 mu g/kg when administered by either subcutaneous injection or oral delivery.
ANTI-INFLAMMATORY AGENTS
申请人:Cambridge Enterprise Limited
公开号:EP1781299B1
公开(公告)日:2010-12-22
Anti-Inflammatory Agents
申请人:Grainger David J.
公开号:US20080194541A1
公开(公告)日:2008-08-14
The invention provides compounds, compositions and uses of compounds of general formula (I) or pharmaceutically acceptable salts thereof, which are 3-aminocaprolactam derivatives, for the preparation of a medicament intended to treat an inflammatory disorder wherein X is —CO—Y—(R
1
)
n
or SO
2
—Y—(R
1
)
n
; and Y is 0 cycloalkyl or polycyloalkyl group (such as an adamantyl, adamantanemethyl, bicyclooctyl, cyclohexyl, cyclopropyl group); or is 0 cycloalkenyl or polycycloalkenyl group.